Alston Cheryl 4
4 · GLOBE LIFE INC. · Filed Jun 26, 2026
Research Summary
AI-generated summary of this filing
Globe Life (GL) Director Cheryl Alston Exercises Options, Sells Shares
What Happened
- Cheryl Alston, a director of Globe Life Inc. (GL), exercised stock options to acquire 14,017 shares at an exercise price of $105.56 per share (total cost ≈ $1,479,635) on June 25, 2026. On the same day she sold a portion of those shares in open-market transactions: 2,750 shares @ $177.56, 1,010 shares @ $178.71, 1,934 shares @ $180.13, and 2,564 shares @ $180.57, for aggregate proceeds of roughly $1,480,134. The Form 4 also reports the conversion/disposition of the derivative (the option) related to the exercise.
Key Details
- Transaction date: June 25, 2026; Form 4 filed June 26, 2026 (timely).
- Exercise: 14,017 shares acquired @ $105.56 (≈ $1.48M).
- Open-market sales: total 8,258 shares sold for ≈ $1.48M across four tranches (prices ranged roughly $177.32–$181.20 per share; see footnotes for per-tranche ranges).
- Derivative entry: 14,017 derivative units converted/disposed at $0 (represents option conversion on exercise).
- Footnote: Includes 26.086 shares acquired via the company’s dividend reinvestment plan since last report.
- Shares owned after the transactions: the Form 4 does not disclose total post-transaction holdings (net increase of 5,759 shares from the exercise before the sales, not counting prior holdings).
Context
- This was an option exercise followed by same-day sales of a portion of the resulting shares — a common pattern where exercised shares are sold (partially or fully) to cover the exercise cost and taxes. The filing shows both an acquisition (exercise) and sales; purchases (exercises) can be viewed as an insider realizing value from vested awards, while the open-market sales are routine dispositions.
Insider Transaction Report
Form 4
Alston Cheryl
Director
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-06-25$105.56/sh+14,017$1,479,635→ 24,879.037 total - Sale
Common Stock
[F2][F3]2026-06-25$177.56/sh−2,750$488,292→ 22,129.037 total - Sale
Common Stock
[F2][F4]2026-06-25$178.71/sh−1,010$180,497→ 21,119.037 total - Sale
Common Stock
[F2][F5]2026-06-25$180.13/sh−1,934$348,364→ 19,185.037 total - Sale
Common Stock
[F2][F6]2026-06-25$180.57/sh−2,564$462,981→ 16,621.037 total - Exercise/Conversion
Director Stock Option (Right to Buy)
2026-06-25−14,017→ 0 totalExercise: $105.56From: 2023-01-02Exp: 2027-01-02→ Common Stock (14,017 underlying)
Holdings
- 0(indirect: Not Applicable)
Common Stock
Footnotes (6)
- [F1]Includes 26.086 shares acquired through the Company's dividend reinvestment plan since date of last report.
- [F2]Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
- [F3]Sales at prices ranging from $177.32 per share to $177.955 per share.
- [F4]Sales at prices ranging from $178.355 per share to $179.195 per share.
- [F5]Sales at prices ranging from $179.45 per share to $180.415 per share.
- [F6]Sales at prices ranging from $180.445 per share to $181.20 per share.
Signature
Cheryl D. Alston by /s/ Chris T. Moore, Attorney-in-fact|2026-06-26